China and U.S. share tech in ASEAN for vaccine diplomacy edge

Drugmakers test new COVID-19 shots in region with eye on local production

20210924N Indonesia vaccine

A healthcare worker in Jakarta holds up a vial of the Sinopharm vaccine. Chinese and U.S. companies are conducting clinical trials for new alternatives in Indonesia. © Reuters

KOYA JIBIKI and TOMOYA ONISHI, Nikkei staff writers

JAKARTA/HANOI -- Vaccine diplomacy by China and the U.S. has entered a new stage as their drugmakers transfer technology to players in Southeast Asia to kick-start local production.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.